|
JPH1050306A
(ja)
*
|
1996-07-31 |
1998-02-20 |
Toyota Autom Loom Works Ltd |
水素吸蔵合金電極の製造方法
|
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
|
US20050085498A1
(en)
*
|
1998-05-28 |
2005-04-21 |
Byrd Edward A. |
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
|
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
|
JP2001107258A
(ja)
*
|
1999-10-06 |
2001-04-17 |
Hitachi Ltd |
無電解銅めっき方法とめっき装置および多層配線基板
|
|
WO2001032148A1
(en)
|
1999-10-29 |
2001-05-10 |
Euro-Celtique, S.A. |
Controlled release hydrocodone formulations
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
EP1118321A1
(fr)
*
|
2000-01-14 |
2001-07-25 |
Ucb, S.A. |
Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
|
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
|
GB0009522D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Smithkline Beecham Plc |
Composition
|
|
CN101317825A
(zh)
|
2000-10-30 |
2008-12-10 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
|
US20060127474A1
(en)
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
|
PL206069B1
(pl)
*
|
2001-06-28 |
2010-06-30 |
Ucb Farchim Sa |
Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę
|
|
HRP20031057B1
(hr)
|
2001-06-28 |
2013-05-31 |
Ucb Farchim Sa, Z.I. Planchy |
Tableta koja sadrži cetirizin i pseudoefedrin
|
|
US20030092724A1
(en)
*
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
AU2003202550A1
(en)
*
|
2002-01-09 |
2003-07-24 |
Ucb, S.A. |
Pharmaceutical formulations with modified release
|
|
PL372904A1
(en)
*
|
2002-04-04 |
2005-08-08 |
Pfizer Products Inc. |
Palatable chewable tablet
|
|
AU2003272601B2
(en)
*
|
2002-09-20 |
2009-05-07 |
Alpharma Pharmaceuticals, Llc |
Sustained-release opioid formulations and methods of use
|
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
|
WO2004052367A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ucb Farchim, S.A. |
Tablet comprising efletirizine and pseudoephedrine
|
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20050281875A1
(en)
*
|
2003-12-17 |
2005-12-22 |
Sovereign Pharmaceuticals, Ltd. |
Promethazine containing dosage form
|
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US20060029664A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing carbetapentane and another drug
|
|
US20050232987A1
(en)
*
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
|
US20050232986A1
(en)
*
|
2003-12-17 |
2005-10-20 |
David Brown |
Dosage form containing promethazine and another drug
|
|
US9492541B2
(en)
*
|
2004-09-14 |
2016-11-15 |
Sovereign Pharmaceuticals, Llc |
Phenylepherine containing dosage form
|
|
US7897172B2
(en)
*
|
2004-05-18 |
2011-03-01 |
L. Perrigo Company |
Tablets exhibiting reduced drug release variability
|
|
US9308164B2
(en)
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
|
US20070003622A1
(en)
*
|
2004-12-16 |
2007-01-04 |
Sovereign Pharmaceuticals, Ltd. |
Diphenhydramine containing dosage form
|
|
WO2006022996A2
(en)
*
|
2004-08-04 |
2006-03-02 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US9592197B2
(en)
*
|
2004-12-16 |
2017-03-14 |
Sovereign Pharmaceuticals, Llc |
Dosage form containing diphenhydramine and another drug
|
|
US7529255B2
(en)
*
|
2005-04-21 |
2009-05-05 |
Microsoft Corporation |
Peer-to-peer multicasting using multiple transport protocols
|
|
SI1909764T1
(sl)
*
|
2005-07-26 |
2015-01-30 |
Ucb Pharma, S.A. |
Farmacevtski sestavki, ki obsegajo levetiracetam in postopek za njihovo pripravo
|
|
US8795723B2
(en)
|
2005-09-09 |
2014-08-05 |
Angelini Pharma Inc. |
Sustained drug release compositions
|
|
JP5269595B2
(ja)
*
|
2005-09-09 |
2013-08-21 |
アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー |
１日１回投与用トラゾドン組成物
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
JP2009523833A
(ja)
*
|
2006-01-21 |
2009-06-25 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
乱用薬剤送達のための製剤および方法
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
KR100753480B1
(ko)
*
|
2006-01-27 |
2007-08-31 |
씨제이 주식회사 |
잘토프로펜 함유 서방성 정제 및 그 제조방법
|
|
US20070253927A1
(en)
*
|
2006-04-13 |
2007-11-01 |
Gwenaelle Jegou |
Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
|
|
US20100172984A1
(en)
*
|
2006-06-06 |
2010-07-08 |
Bijay Kumar Padhi |
tablet dosage form comprising cetirizine and pseudoephedrine
|
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
WO2007149860A1
(en)
*
|
2006-06-19 |
2007-12-27 |
Accu-Break Technologies, Inc. |
Segmented pharmaceutical dosage forms
|
|
US8765178B2
(en)
*
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
US8045677B2
(en)
|
2006-09-25 |
2011-10-25 |
Koninklijke Philips Electronics N V Eindhoven |
Shifting an object for complete trajectories in rotational X-ray imaging
|
|
SI2124556T1
(sl)
|
2006-10-09 |
2015-01-30 |
Charleston Laboratories, Inc. |
Farmacevtske sestave
|
|
WO2008064192A2
(en)
|
2006-11-21 |
2008-05-29 |
Mcneil-Ppc, Inc. |
Modified release analgesic suspensions
|
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
|
AU2008314454A1
(en)
*
|
2007-10-16 |
2009-04-23 |
Labopharm (Barbados) Limited |
Bilayer composition for the sustained release of acetaminophen and tramadol
|
|
EP2219677A1
(en)
*
|
2007-11-21 |
2010-08-25 |
The Procter & Gamble Company |
Preparations, methods and kits useful for treatment of cough
|
|
CA2707980C
(en)
|
2007-12-17 |
2015-05-12 |
Labopharm Inc. |
Misuse preventative, controlled release formulation
|
|
EP2240022B1
(en)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Bilayered tablets comprising oxycodone and promethazine
|
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
|
CA2746888C
(en)
|
2008-12-16 |
2015-05-12 |
Labopharm (Barbados) Limited |
Misuse preventative, controlled release formulation
|
|
EP2381937A2
(en)
|
2008-12-31 |
2011-11-02 |
Upsher-Smith Laboratories, Inc. |
Opioid-containing oral pharmaceutical compositions and methods
|
|
EP3311667A1
(en)
|
2009-07-08 |
2018-04-25 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
BR112012008317A2
(pt)
|
2009-09-17 |
2016-03-22 |
Upsher Smith Lab Inc |
produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
|
|
MX2012012991A
(es)
|
2010-05-11 |
2012-11-30 |
Cima Labs Inc |
Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol.
|
|
CN102302497A
(zh)
*
|
2011-05-18 |
2012-01-04 |
天圣制药集团股份有限公司 |
一种治疗过敏性鼻炎的制剂及其制备方法
|
|
PL2956120T3
(pl)
|
2013-02-13 |
2020-08-10 |
The Procter & Gamble Company |
Leki o smaku anyżu
|
|
KR102070076B1
(ko)
*
|
2013-05-03 |
2020-01-29 |
주식회사 제닉 |
탄산 함유 입자를 포함하는 필름
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
JP6461186B2
(ja)
|
2014-03-11 |
2019-01-30 |
レッド ヒル バイオファーマ リミテッドＲｅｄＨｉｌｌ Ｂｉｏｐｈａｒｍａ Ｌｔｄ． |
悪心、嘔吐または下痢の症状を処置するためのオンダンセトロン徐放固形製剤
|
|
US10179109B2
(en)
|
2016-03-04 |
2019-01-15 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
|
|
RU2687715C1
(ru)
*
|
2018-05-07 |
2019-05-15 |
Федеральное государственное бюджетное учреждение науки Институт горного дела Дальневосточного отделения Российской академии наук |
Способ комбинированной разработки россыпных месторождений золота
|
|
US20220062200A1
(en)
|
2019-05-07 |
2022-03-03 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
US11324707B2
(en)
|
2019-05-07 |
2022-05-10 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
KR102073185B1
(ko)
*
|
2019-07-16 |
2020-02-04 |
(주)위바이오트리 |
활성성분을 포함하는 변성 다중층 수산화물 구조체를 포함하는 금속 수산화물 복합체 및 이의 제조 방법
|